Skip to main content

Solventum Corp statistics

  • SOLV · NYSE
  • Medical devices
  • Health Care Technology
  • S&P 500
$89.08+0.30%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$19.76B
EV / EBITDA20.26
EV / sales2.42

Share price

Latest close$89.08
Day's change+0.3%
52-week high$94.16
52-week low$62.38
From 52-week high−5.4%
Return · 1 month+3.8%
Return · 3 months+0.5%
Return · year to date+12.4%
Return · 1 year+20.7%
Beta · 1 year against the S&P 5000.57
50-day average$87.52
200-day average$78.84
RSI 1455.3
Average volume · 20 sessions1.3M

Margins and returns

For fiscal 2025, as filed.

Gross margin53.5%
Operating margin26.2%
Net margin18.7%
Free cash flow margin−0.1%
Return on equity38.9%
Return on assets13.8%
Return on invested capital17.4%
Return on capital employed19.0%
Stock-based compensation / revenue1.9%

Financial position

At the end of fiscal 2025.

Cash and equivalents$878.0M
Total debt$5.25B
Net debt$4.37B
Current ratio1.23
Debt / equity1.04
Net debt / EBITDA1.64

Shares and dividends

For fiscal 2025, as filed.

Diluted shares175M

Taxes

For fiscal 2025, as filed.

Income tax expense$157.0M
Effective tax rate9.2%

SOLV in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.